MBA
LAW
LANGUAGES

ORCHID CELLMARK INC ORCH (NASDAQ)

$ 1.55

19:09

Sponsored by

Change: +0.08 (+5.44%)
Volume: 277,400

Avg. Volume:	100660
P/E Ratio:	0
EPS (Annual):	-0.13
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	29,970
Institutional Shareholders:	67.15%

Last:	1.55
Change:	+0.08 (+5.44%)
Prev. Close:	1.47
Open:	1.40
Day's Range:	1.15 - 1.55
52wk Range:	1.15 - 5.72
Market Value:	47,950
Beta:	1.85

12-month EPS Change:	37.50%
Total Return Last 12 Months:	-72.42%
Total Return Last 3 Years:	-117.26%
Total Return Last 5 Years:	-82.18%
5-Year Revenue Growth Rate:	19.59%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	-98.65%

Headlines on ORCH

Alert me

Last Call: Sequenom shares decline

(NEW YORK)Shares of genetic test maker Sequenom Inc. fell Tuesday, a day after the company was served with a patent infringement lawsuit, though analysts and the company's chief financia...READ MORE

Jun 10, 2008 3:24PM

Keywords: SQNM, BEC, ORCH

Beckman and partner Orchid sue Sequenom

(NEW YORK)Genetic and molecular diagnostic company Sequenom Inc. said Monday it is being sued over its iPLEX DNA analysis system by Beckman Coulter Inc. and Orchid Cellmark Inc.READ MORE

Jun 09, 2008 5:28PM

Keywords: SQNM, BEC, ORCH